课题基金 / 基金详情

Pathogenic role of CDA1 via its profibrotic action in diabetic nephropathy

Pathogenic role of CDA1 via its profibrotic action in diabetic nephropathy
CDA1 通过其促纤维化作用在糖尿病肾病中发挥致病作用
批准号:
nhmrc : 472638
负责人:
Dr Zemin Cao
金额:
$32.26万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2010-12-31

项目摘要

项目成果

Dr Zemin Cao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We cloned a CDA1 several years ago and found that it played a major role in controlling a series of molecular events leading to production and accumulation of extracellular matrix causing scarring, as seen in diabetic nephropathy. This project aims to study the biological functions and molecular mechanisms of CDA1 in the context of diabetic nephropathy, hence allowing us to consider CDA1 as a molecular target for drug development to treat this condition and related complications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel strategy to reduce renal fibrosis
  • 批准号:
    nhmrc : 1010098
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $38.56万
  • 财政年份:
    2011
  • 负责人:
    Dr Zemin Cao
  • 依托单位:
Progressive renal and vascular disease: pivotal role of the AT2 receptor
  • 批准号:
    nhmrc : 225114
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $18.93万
  • 财政年份:
    2003
  • 负责人:
    Dr Zemin Cao
  • 依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
  • 批准号:
    82371070
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵培泉
  • 依托单位: